NCT07227077 Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
| NCT ID | NCT07227077 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-02 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Eligibility Criteria
Inclusion Criteria: 1. Age greater than or equal to 65 years. 2. Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment. 3. Fluent in spoken and written English. 4. Patient has access to smartphone 5. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Patient has metastatic disease. 2. Patient has cancer recurrence.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07227077 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07227077 currently recruiting?
Yes, NCT07227077 is actively recruiting participants. Contact the research team at kclohesey@mcw.edu for enrollment information.
Where is the NCT07227077 trial being conducted?
This trial is being conducted at Milwaukee, United States.
Who is sponsoring the NCT07227077 clinical trial?
NCT07227077 is sponsored by Medical College of Wisconsin. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.